Mikoderil external solution. 1% 10ml-vial cap. ind.upak.

$10.82

Mikoderil external solution. 1% 10ml-vial cap. ind.upak.

Quantity:

SKU: 1700304474 Categories: , , Tag:

Description

Composition
Active substance:
1 ml of solution contains:: naftifine hydrochloride – 10.0 mg.
Excipients:
Propylene glycol – 50.0 mg of ethanol (ethyl alcohol 95%) – 400.0 mg purified water – up to 1 ml.
Description:
Transparent, colorless or slightly yellowish solution with an ethanol odor.
Product form:
A solution for external application of 1%.
10 ml, 20 ml vials, droppers dark (amber) glass, capped, stoppered polyethylene dropper and a polypropylene caps control the first opening.
Each vial-IV together with instructions for use placed in a pile of cardboard.
Contraindications
Hypersensitivity to naftifine or propylene glycol; pregnancy and lactation (safety and efficacy in these patients has not been studied).
Medication contraindicated application on the wound surface.
Carefully
Children’s age (clinical use experience is limited).
Dosage
1 %
Indications
Fungal infection of smooth skin and skin folds (tinea corporis, tinea inquinalis); interdigital mycosis (tinea manum, tinea pedum); Nail fungal infections (onychomycosis); Skin candidiasis; chromophytosis; inflammatory dermatomycosis (with or without itching it).
Interaction with other drugs
Not studied interactions with other drugs.
Overdose
No cases of overdose have been reported.
pharmachologic effect
Pharmacological group:
Antifungal agent for external use.
Pharmacodynamics:
Mikoderil®, topical solution, 1% – antifungal means for external use, relating to the class of allylamine. Its active ingredient is naftifine. The mechanism of action is associated with inhibition of squalene epoxidase 2.3 and it leads to decrease in the formation of ergosterol, a component of fungal cell walls. Naftifine, affecting squalene epoxidase not affect the cytochrome P-450.
Naftifine active against dermatophytes such as Trichophyton, Epidermophyton, Microsporum, yeasts and yeast-like fungi (Candida spp., Pityrosporum), fungi (Aspergillus) and other fungi (e.g. Sporothrix schenckii). In against dermatophytes and Aspergillus acts fungicidally naftifine. With respect to the preparation of yeasts exhibits fungicidal or fungistatic activity depending on the microorganism strain. Naftifine has antibacterial activity against Gram-positive and Gram-negative microorganisms that cause secondary bacterial infection.
Naftifine possesses anti-inflammatory action, which contributes to the rapid disappearance of the symptoms of inflammation, especially pruritus.
Pharmacokinetics:
When applied topically naftifine quickly penetrates into the skin, creating a stable antifungal concentration in its various layers that can be run once a day.
Pregnancy and breast-feeding
Use of the drug during pregnancy and lactation is not recommended (safety and efficacy in these patients has not been studied).
Conditions of supply of pharmacies
Without a prescription.
side effects
In some cases, local reactions can occur: dry skin, skin redness and burning. Side effects are reversible and do not require discontinuation of treatment. If any of these instructions side effects are compounded, or observed any other side effects not mentioned in the instructions, you should immediately inform your doctor.
special instructions
Mikoderil®, topical solution, 1% is effective in the treatment of fungal infections affecting the skin area with hyperkeratosis, as well as in areas of hair growth.
Required treatment course.
Avoid getting product in eyes and open wounds.
Use in Pediatrics
Precautions should use the drug in children.
Effects on ability to drive vehicles and other mechanisms
Mikoderil®, topical solution, 1% does not adversely affect the ability to drive, and perform other activities that require concentration and psychomotor speed reactions.
Storage conditions
Store at a temperature not higher than 25 C. Keep out of reach of children.
Dosing and Administration
Outwardly.
For ringworm, candidiasis and skin.
Mikoderil®, topical solution, 1% applied 1 time a day to the affected skin surface and its neighboring sections after careful cleaning and drying, capturing about 1 cm healthy area of ​​skin around the edges of the affected area. Duration of treatment: the dermatomycosis – 2-4 weeks (if necessary – up to 8 weeks) at candidiasis – 4 weeks.
When nail infections (onychomycosis).
Before the first use of the drug was removed as much as possible the affected part of the nail clippers and a nail file. The drug is used 2 times a day, duration of treatment for onychomycosis – up to 6 months. In order to prevent recurrence of infection should continue to use the drug for at least 2 weeks after the disappearance of clinical symptoms.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

OTISIFARM

There are no reviews yet.

Add your review